Glucagon-like peptide-1 (GLP-1) compounds have emerged as a compelling therapeutic avenue for managing metabolic USA approved manufacturer for Retatrutide conditions. These naturally occurring hormones are secreted by the gut in response to food intake, stimulating insulin secretion and suppressing glucagon secretion. GLP-1 peptides demonstrate pro